Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction

Abstract

Current clinical therapy of non-small cell lung cancer depends on histo-pathological classification. This approach poorly predicts clinical outcome for individual patients. Gene expression profiling holds promise to improve clinical stratification, thus paving the way for individualized therapy.